scholarly journals Phase 2 study of treatment selection based on tumor thymidylate synthase expression in previously untreated patients with metastatic colorectal cancer: A trial of the ECOG-ACRIN Cancer Research Group (E4203)

Cancer ◽  
2017 ◽  
Vol 124 (4) ◽  
pp. 688-697
Author(s):  
Neal J. Meropol ◽  
Yang Feng ◽  
Jean L. Grem ◽  
Mary F. Mulcahy ◽  
Paul J. Catalano ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Cancer Research ◽  
Metastatic Colorectal Cancer ◽  
Thymidylate Synthase ◽  
Research Group ◽  
Treatment Selection ◽  
Phase 2 ◽  
Phase 2 Study

scholarly journals A phase 2 study of panitumumab with irinotecan as salvage therapy in chemorefractory KRAS exon 2 wild-type metastatic colorectal cancer patients

2019 ◽  
Vol 121 (5) ◽  
pp. 378-383 ◽  
Author(s):  
Elena Elez ◽  
Carles Pericay ◽  
Manuel Valladares-Ayerbes ◽  
Inmaculada Bando ◽  
Maria Jose Safont ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Salvage Therapy ◽  
Phase 2 ◽  
Wild Type ◽  
Exon 2 ◽  
Phase 2 Study ◽  
Colorectal Cancer Patients ◽  
Kras Exon

ENCORE 601: A phase 2 study of entinostat in combination with pembrolizumab in patients with microsatellite stable metastatic colorectal cancer.

2018 ◽  
Vol 36 (15_suppl) ◽  
pp. 3557-3557 ◽  
Author(s):  
Nilofer Saba Azad ◽  
Keisuke Shirai ◽  
Autumn Jackson McRee ◽  
Mateusz Opyrchal ◽  
Douglas Buckner Johnson ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase 2 ◽  
Phase 2 Study

Phase 2 Study of Modified Irinotecan and Bolus 5-Fluorouracil/l-Leucovorin in Japanese Metastatic Colorectal Cancer Patients

2012 ◽  
Vol 29 (3) ◽  
pp. 287-296
Author(s):  
Eishi Baba ◽  
Hiromitsu Fujishima ◽  
Akitaka Makiyama ◽  
Keita Uchino ◽  
Risa Tanaka ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Cancer Patients ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Colorectal Cancer Patients

scholarly journals A phase 2 study of the PARP inhibitor veliparib plus temozolomide in patients with heavily pretreated metastatic colorectal cancer

Cancer ◽  
2018 ◽  
Vol 124 (11) ◽  
pp. 2337-2346 ◽  
Author(s):  
Michael J. Pishvaian ◽  
Rebecca S. Slack ◽  
Wei Jiang ◽  
A. Ruth He ◽  
Jimmy J. Hwang ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Parp Inhibitor ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Heavily Pretreated

scholarly journals Fluorouracil and bevacizumab plus anakinra for patients with metastatic colorectal cancer refractory to standard therapies (IRAFU): a single-arm phase 2 study

2018 ◽  
Vol 7 (9) ◽  
pp. e1474319 ◽  
Author(s):  
Nicolas Isambert ◽  
Alice Hervieu ◽  
Cedric Rébé ◽  
Audrey Hennequin ◽  
Christophe Borg ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Phase 2 ◽  
Phase 2 Study

scholarly journals A randomized Phase 2 study comparing different dosing approaches of induction treatment (first cycle) of regorafenib in metastatic colorectal cancer (mCRC) patients

2017 ◽  
Vol 28 ◽  
pp. v206-v207
Author(s):  
G. Argilés Martinez ◽  
E. Sanz-Garcia ◽  
M. Valladares-Ayerbes ◽  
J.M. Viéitez ◽  
P. Garcia-Alfonso ◽  
...  
Keyword(s):  
Colorectal Cancer ◽  
Metastatic Colorectal Cancer ◽  
Induction Treatment ◽  
Phase 2 ◽  
Phase 2 Study ◽  
Randomized Phase 2
Sign in / Sign up

Export Citation Format

Share Document